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ABSTRACT 
In the testis, several cell types are needed to ensure male fertility, among them the 
testosterone-producing Leydig cells. Testosterone supports the maturation of sperm 
and maintains the male phenotype. Functional Leydig cells are therefore required to 
prevent testicular malfunction. Yet in contrast to their well-established role in the 
testis, the origin of the adult Leydig cell lineage has largely remained unclear. 
A potential reservoir for putative stem Leydig cells are the peritubular myoid cells, 
which show characteristics of pluripotency as well as steroidogenic capacity and can 
be isolated to study the differentiation mechanisms of steroidogenic cells. The scope 
of this work is to elucidate cells and pathways involved in the underlying processes. 
 
Common to all stages of Leydig cell development is the presence of the platelet-
derived growth factor receptor alpha (PDGFRα). Stem Leydig cells have been 
described to be PDGFRα-positive and to not express the luteinizing hormone 
receptor (LHR), a classical marker for differentiated Leydig cells. 
To identify the stem Leydig cell in the testis, we first analyzed the two steroidogenic 
cell types in the postnatal rodent testis. Both, the fetal Leydig cells and the 
peritubular cells were PDGFRα positive and showed a transient capacity to produce 
steroids. Stimulation of the cAMP-PKA pathway increased the steroidogenic 
potential in both cell types. However, while the FLCs were responsive to hCG 
stimulation, the PTCs expressed no LHR and their steroid production did not 
increase during hCG treatment. The isolated PDGFRα-positive, LHR-negative rat 
PTCs expressed markers for pluripotent, steroidogenic and myoid cells, indicating 
that they include putative stem Leydig cells. 
 
Subsequently, we examined the transferability of the rodent data into humans. We 
found that the peritubular cells in the adult human testis (HTPC) also expressed the 
PDGFRα and showed characteristics of pluripotent as well as steroidogenic cells. 
Stimulation of the cAMP-PKA pathway in isolated HTPCs increased the steroid 
production, underscoring the similarities between rat and human Leydig cell 
development. 
 
To be able to study early differentiation mechanisms in detail, the rapidly developing 
field of stem cell technology opens new possibilities. As the overexpression of the 
steroidogenic factor 1 (SF-1) has been described to induce the differentiation of 
steroidogenic cells from mesenchymal and embryonic stem cells, we characterized 
seven human embryonic stem cell lines with the aim of identifying similar factors. We 
found that all seven cell lines express different marker profiles for differentiating 
cells, with one cell line, i.e. HS361 showing characteristics of Sertoli-like cells and 
another cell line, i.e.HS420, expressing early differentiation marker for steroidogenic 
cells. Further characterization and differentiation of this cell line could increase our 
understanding of the development of steroidogenic cells. 
 
In summary, this work shows that the peritubular cell population in the testis contains 
putative stem Leydig cells and that these cells can be stimulated to become 
steroidogenic. The cAMP-PKA pathway plays an important role in the maintenance 
of steroidogenesis and prevents dedifferentiation under in vitro conditions. We 
furthermore identified candidate human embryonic stem cell lines for the study of the 
underlying mechanisms of gonadal cell development.  
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  1 
1 INTRODUCTION 
Infertility and its treatment is the primary concern in modern reproductive medicine. It 
is a growing problem affecting around 10 % of Western couples. The male factor 
with impaired sperm production or function accounts for half of the cases (WHO, 
2008). 
The arrival of stem cell technology has opened more possibilities to the field of 
regenerative medicine, and new strategies to approach male infertility have 
emerged.  
A better understanding of key testicular cell types and their origin is crucial for the 
development of novel therapeutic approaches to testicular malfunction. 
Leydig cells (LC) are the major source of steroids in the testis and important for the 
regulation of spermatogenesis and male development. The elucidation of paracrine 
factors and corresponding signaling pathways that control the differentiation process 
of stem Leydig cells into the adult Leydig cell lineage might open possibilities for 
pharmacological and dietary approaches to treat men with Leydig cell dysfunction or 
age-related decline in Leydig cell function. 
 
Recent findings have shown that peritubular myoid cells (PTC) may contain putative 
stem Leydig cells (PSLC) [1]. The potential stem cell activity of PTCs could be used 
to restore spermatogenesis and testicular development. Adult PTCs could also serve 
as a source of somatic stem cells and may have potential in regenerative medicine. 
The identification of mechanisms underlying gonadal cell differentiation and the 
subsequent use of pluripotent stem cells in restoring spermatogenesis/ 
steroidogenesis is an important approach towards re-establishing fertility in a 
subpopulation of infertile or sub-fertile males. For example, male survivors of 
childhood cancer that have undergone gonadotoxic treatment are an increasing 
group of these patients. 
 
1.1 INFERTILITY 
Infertility is defined as the inability to conceive children after one year of frequent 
unprotected intercourse [2]. It has become a growing problem in the Western world 
concerning 10-15% of all couples (WHO) [3].  
In about 50% of the infertility cases the male factor is involved and predominates in 
about 20%. The female factor is responsible for about 38% of the cases and the 
remaining 12% have no clear diagnosis and are therefore registered as idiopathic 
infertility [4]. 
Male fertility depends on complete spermatogenesis with normal hormonal levels, 
functional epididymal maturation and normal storage and transport of sperm [4].  
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Possible causes for male infertility include the dysfunction of the hypothalamic-
pituitary gonadal axis (e.g. hypothalamic/ pituitary diseases that induce secondary 
hypogonadism) and the male genitalia (e.g. testicular diseases like primary 
spermatogenesis failure, anatomical abnormalities or primary hypogonadism and 
posttesticular defects generating obstructive azoospermia) [5]. 
Infertility can also result from cancer or other medical treatment, genetic disorders, 
sexually transmitted diseases, congenital malformations, surgery of the male 
genitalia or the inguinal region or may be caused by psychosexual problems [4].  
 
1.2 THE TESTIS 
The testis is one of the male genital organs. Its main functions are the production 
and maturation of sperm (spermatogenesis), as well as the production and secretion 
of androgens (steroidogenesis).  
The testicular function is regulated by the hypothalamus and the pituitary, as well as 
by paracrine and autocrine factors, which are involved in both the spermato- and 
steroidogenesis. 
For optimal function, the testes are located in the scrotum with organ temperature 
slightly below the body core temperature (human: 37 ̊ C). The adult human testis is 
approximately 4-5 cm long, weighs 20 g and has a volume of 12-30 ml [6]. 
Histologically, the organ consists of about 600, closely packed seminiferous tubules, 
which correlate to about 360 m of seminiferous epithelium [2]. 
 
1.2.1 Histology 
Due to its tubular structure, the organ can be divided into a tubular and an interstitial 
compartment, which are separated from each other by a basal lamina (Figure 1). 
The integrity of both compartments is necessary for the quantitatively and 
qualitatively normal sperm production. 
The peritubular cells surrounding the tubuli seminiferi, the Sertoli and the germ cells 
build the tubular compartment, where the spermatogenesis takes place. The tubular 
compartment accounts for about 60-80% of the total testicular volume [2]. 
The interstitial compartment consists of Leydig cells, which represent 10-20% of the 
interstitial volume [2], macrophages and other immune-competent cells, vascular 
smooth muscle cells and pericytes.  
In humans, the interstitium corresponds to about 12-15% of the total testicular 
volume [2]. 
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Figure 1: A: Testicular section of a healthy 23 year old man (Picture provided by J.-B. Stukenborg); 
B: Overview of the same testicular section with color coded cell nuclei: orange: peritubular cells, 
yellow: Leydig cells, green: Sertoli cells, blue: germ cells 
 
1.2.1.1 Peritubular cells 
The peritubular cells are smooth-muscle-like cells that build the wall of the tubuli 
seminiferi and are involved in sperm transport by tubular contractions. Together with 
the Sertoli cells, they are part of the spermatogonial stem cell niche and secret 
factors that orchestrate testicular functions. An in-depth description of the peritubular 
cells follows in chapter 1.4. 
1.2.1.2 Sertoli cells 
The Sertoli cells were first described in 1865 by Enrico Sertoli. They account for 35-
40% of the volume of the germinal epithelium [2] and are the supporting structure of 
the germinal epithelium. 
Their main function is to nourish and support the germ cells during differentiation. 
Complete spermatogenesis depends on Sertoli cells, as they are in a constant and 
intimate interaction with germ cells during all stages of their differentiation [7]. 
During fetal development, the Sertoli cells secrete factors such as Dhh and PDGF 
and thereby support fetal Leydig cell development [8]. In the prepubertal testis, their 
role is to maintain the peritubular phenotype and they are involved in the 
differentiation of the adult Leydig cell lineage [9]. 
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The tight junctions of the Sertoli cells build the blood-testis barrier, which is formed 
when the first germ cells undergo meiotic division. The blood-testis barrier is part of 
the testicular defense mechanisms and separates the meiotic germ cells from the 
circulating blood. 
The Sertoli cell function is hormonally regulated. Sertoli cells express FSH- and 
androgen receptors and can aromatize testosterone to estrogen. They secrete 
several proteins such as AMH, Sry, Sox9, transferrin and the androgen-binding 
protein, which are specific for Sertoli cells and can be used as markers for cell 
identification. 
A healthy human testis with complete spermatogenesis contains 800-1200*106 
Sertoli cells [2]. The relation between Sertoli and germ cells has been determined at 
10:1.5 germ cells/ spermatozoa per Sertoli cell [2]. The total number of Sertoli cells 
regulates the final testicular size.  
A gene knock-out in the murine Sertoli cell specific androgen receptor (AR) resulted 
in a normal male phenotype with reduced testicular size due to spermatogenetic 
arrest in meiosis [10, 11]. 
1.2.1.3 Germ cells 
The germ cells are responsible for transfer of genetic information from one 
generation to the next. They differentiate in the tubular wall towards the lumen. Their 
development and function will be discussed in more detail in chapter 1.2.2.1. 
1.2.1.4 Leydig cells 
The Leydig cells are the steroid-producing cells of the testis. Their function is 
important for functional spermatogenesis and the well-being of the male. 
Steroidogenesis and the different Leydig cell types will be discussed in more details 
in the chapters below. 
1.2.1.5 Macrophages and other immune-competent cells 
The immune-competent cells play an important role in the regulation of testicular 
function. The testis is a unique immunoregulatory environment with limited immune 
response. While immune cells have unrestricted access to the interstitium, they 
cannot enter the tubular compartment because of the blood-testis-barrier.   
Interestingly, the macrophage/ Leydig cell ratio differs between species. While 
rodents have about 1 macrophage per 4-5 LCs [12], in humans 1 macrophage 
corresponds to 10-50 Leydig cells [2]. 
Macrophages are involved in the regulation of Leydig cell development and function 
by secretion of several immunoregulatory factors (e.g. IL1β, IL1α, TNFα, LIF, IL2, 
IL6, TGFβ, prostaglandin and 25-OH-cholesterol) [13-15]. 25-OH-cholesterol 
bypasses StAR and supports basal steroidogenesis.  
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1.2.1.6 Vascular smooth muscle cells and pericytes 
Vascular smooth muscle cells surround the blood vessels in the interstitium. Their 
role as putative precursors for the Leydig cell lineage has been discussed [16]. 
 
1.2.2 Testis Function 
1.2.2.1 Spermatogenesis 
Spermatogenesis refers to a series of differentiation steps leading from 
spermatogonia to mature spermatozoa and is divided into four phases, namely 
spermatogoniogenesis, forming of spermatids, spermiogenesis and spermiation 
(Figure 2). 
Spermatogoniogenesis is the mitotic proliferation and differentiation of diploid germ 
cells (spermatogonia). The following meiotic division of double-diploid germ cells 
(spermatocytes) results in haploid germ cells called spermatids. This step involves 
two meiotic divisions: In meiosis I, a daughter cell with 23 pairs of chromosomes, the 
diploid primary spermatocyte is formed, in meiosis II, the cells containing diploid 
chromosomes are split into two haploid secondary spermatocytes with 23 single 
chromosomes. 
During the following spermiogenesis, spermatids mature into spermatozoa. An 
acrosome cap is formed and the remaining cytoplasm is disposed in form of a 
residual body. The spermatozoa are then released from the germinal epithelium into 
the tubular lumen (spermiation) [2] and transported to the epididymidis for final 
maturation . 
Spermatogenesis begins in puberty and is located in the tubuli seminiferi. The 
spermatogonial stem cells (SSCs) are located in a niche formed by the Sertoli and 
the peritubular cells. The differentiating cells migrate from the basal lamina towards 
the lumen of the seminiferous tubuli. During their passage, they are nourished and 
protected by the Sertoli cells. Once started, spermatogenesis occurs throughout the 
entire adult life cycle. 
The entire process of spermatogenesis is hormonally regulated by testosterone and 
LH/FSH, and exhibits major interspecies differences between rodents and humans. 
In rodents, spermatogenesis involves 12 stages: three undifferentiated 
spermatogonia types (i.e. A single, A paired, A aligned) and six differentiating 
spermatogonia (i.e. A1, A2, A3, A4, intermediate and B spermatogonia) giving rise to 
two daughter cells per division. The secondary spermatocytes, also called type B 
spermatogonia, further differentiate through meiosis into spermatozoa and finally into 
mature sperm. This results in 4096 elongated spermatids from one SSC in each 
cycle of spermatogenesis. 
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Figure 2: Schematic overview of the human spermatogenesis adapted from J-B. Stukenborg  
 
In contrast, human spermatogenesis involves six stages and includes three different 
types of spermatogonia: A dark, the self-renewing stem cell, A pale and B 
spermatogonia [17]. The subsequent differentiation process of B spermatogonia is 
similar to the spermatogenesis in rodents [18, 19] (Figure 2). 
Spermatogenesis takes 64 days with one spermatogenic cycle every 16 days 
[2].One A pale spermatogonium only gives rise 16 elongated spermatids in one 
cycle. 
 
1.2.2.2 Steroidogenesis  
Steroidogenesis describes the synthesis of steroids from cholesterol, with 
testosterone being the final product in adult Leydig cells. In addition to Leydig cells, 
steroidogenesis also occurs in the adrenals and in the theca cells of the ovary. There 
are several sources for the substrate cholesterol: de novo synthesis, from cholesteryl 
ester storage, supplied exogenously by lipoproteins or retrieved from the plasma 
membrane [20]. 
The two main organelles involved in steroidogenesis in Leydig cells are the 
mitochondria and the smooth endoplasmatic reticulum (SER). Cholesterol is 
transported to the mitochondrion for conversion to pregnenolone the side chain 
cleavage enzyme P450scc. Following the transport into the smooth endoplasmatic 
reticulum, several conversion steps, involving the enzymes 3βHSD, P450c17 and 
17βHSD, convert pregnenolone into testosterone, which is finally released into the 
cytoplasm (Figure 3) [21, 22]. 
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Figure 3: Overview of steroidogenesis in an adult Leydig cell. StAR and PBR transport cholesterol to 
the inner mitochondrial membrane and into the mitochondrion where the conversion of cholesterol to 
pregnenolone occurs. Subsequently, pregnenolone is transported to the smooth endoplasmatic 
reticulum where it is converted into testosterone which is then released into the cytoplasm prior to its 
release from the cell. Blue: stimulators of steroidogenesis, dark red: conversion steps and enzymes 
 
Steroidogenesis is regulated both acutely and long term. StAR and a protein 
complex (transduceosome) including PBR (TSPO), VDAC-1 (voltage-dependent 
anion channel), PAP7 (TSPO-associated protein 7) and PKAR1A (protein kinase A 
regulatory subunit 1α) are involved in the acute regulation of steroidogenesis through 
control of cholesterol transport from the outer to the inner mitochondrial membrane 
[23-25]. Substrate availability is a rate-limiting step in steroidogenesis.  Long-term 
regulation of steroidogenesis is facilitated via gene transcription changes involving 
LH stimulation [20]. 
Several pathways such as the cAMP-PKA pathway, the protein kinase c and the 
intracellular Ca2+ signaling are involved in the regulation of steroidogenesis [20]. 
 
1.2.2.3 Testosterone 
Testosterone is the most important androgen in men. About 95% of the circulating 
androgens are synthesized in the testes, where the Leydig cells produces about 6-
7mg per day [2]. Normal serum values are around 12-30 nmol/ L. 
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Androgens are responsible for the genesis of the male sexual characteristics. During 
embryonic development, the sexual organs are formed and their further development 
towards the male phenotype continues in puberty. 
In the testis, several cell types express the androgen receptor, such as germ, Sertoli, 
Leydig, and peritubular cells. Androgens are involved in the regulation of meiotic and 
postmeiotic germ cell development and Sertoli cell proliferation, and control the 
maintenance of complete spermatogenesis, spermatocyte and spermatid 
development via the Sertoli cells [26]. In the Leydig cells, androgens regulate the 
testosterone production via a feedback loop and are required for normal male fertility 
[27]. Contractility of the peritubular cells, which ensures normal spermiation, is 
governed by androgens [28]. 
Testosterone has several other target organs in addition to the testis. It influences 
growth of all male sexual organs, i.e. penis, prostate, seminal vesicles and 
epididymidis. In the brain, it regulates cognitive function, socialization, dominance 
and libido. Furthermore, testosterone regulates both body growth and proportion 
and, it is involved in erythropoiesis, muscle and bone anabolism and lipid 
metabolism. It increases skin hair growth, balding and  sebum production and it 
initiates growth of the larynx during puberty, resulting in a lower voice in males [2]. 
Testosterone deficiency leads to osteoporosis, pallor, wrinkled skin, anemia, muscle 
atrophy, psychological changes and loss of libido. 
 
1.3 THE LEYDIG CELL 
The Leydig cells are the testosterone producing cells in the testis and thereby the 
main testosterone producer in men. The most important LC markers are LHR, 
3βHSD, INSL3. Adult human testes contain about 200*106 Leydig cells [2], while the 
adult rat testes contain approximately 50*106 Leydig cells [29]. 
LCs were first described in animals by Franz Leydig in 1850 [30] and in men by 
Albert Kölliker in 1854 [31], but their role remained unclear until testosterone was 
isolated for the first time in 1935 [32]. It took another 30 years until in 1965 the first 
biochemical evidence of this Leydig cell function was provided [33, 34].  
From a developmental point of view Leydig cells can be divided into different 
subtypes. In the fetus, fetal Leydig cells (FLCs) produce testosterone and the INSL-
3, which is needed for normal development of the male external genitalia and the 
testis descent into the scrotum. Androgen production declines after birth. In humans, 
there is a quiescent period during childhood. In puberty, the Leydig cell differentiation 
resumes and the mature adult Leydig cells are formed via progenitor and immature 
cells. They produce androgens during the entire adult life span [35]. 
To distinguish between the two Leydig cell generations, fetal and adult, respectively, 
Mc2r was described as a marker for fetal Leydig cells [36], and Sult1e1 for the adult 
Leydig cell lineage [37]. 
  9 
 
1.3.1 The fetal Leydig cell (FLC) 
 
 
Figure 4: Schematic overview of a fetal Leydig cell with a big nucleus and nucleolus, lipid droplets 
(grey), smooth endoplasmatic reticulum and mitochondria 
 
The origin of fetal Leydig cells has been a matter of debate for a long time. Evidence 
has been provided for their development from the adrenal-gonadal primordium [38], 
the neural crest [39, 40], the mesonephros [41, 42] or the coelomic epithelium [43, 
44]. In rodents, they first appear around E12.5 (mice) and E14.5 (rat), whereas in 
humans, they are found from week 6-7 of pregnancy, immediately following the 
formation of the testis cords. 
FLCs differentiate in the interstitium into steroidogenic cells. They are of oval shape 
and possess abundant smooth endoplasmatic reticulum, mitochondria and lipid 
droplets (Figure 4). While in the interstitium, they form clusters that are surrounded 
by a basal lamina. Their formation is dependent on Dhh and PDGF-A, two factors 
produced by Sertoli cells [8, 45], but independent of LH because LHR expression is 
not found until after the onset of FLC development. Furthermore, a LHR-knock out 
mouse shows unchanged testosterone levels during the fetal period [46].  
FLCs are competent to produce testosterone at E 15.5 in rats [29, 47] and from 
week 6-7 in humans [45]. Testosterone controls the development of the male 
characteristics by formation of the internal and the external genitalia as well as 
influencing neuroendocrine functions. Testosterone production peaks in week 14-18. 
The cells continue to proliferate and reach their maximal number in week 15 (rat 
E19.5) and during week 18-38 they start to involute. Around birth about 18*106 cells 
are left, which decrease in volume [48] and remain quiescent until puberty. 
There is a second wave of testosterone production after birth, also known as mini 
puberty, taking place at month 2-3 [49, 50]. 
In addition, FLCs produce Insulin-like 3 (Insl3), a growth factor that is important for 
the abdominal phase of the testicular descent- through stimulation of the growth of 
the gubernaculum [51]- and as a survival factor for germ cells. 
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Figure 5: Schematic overview of possible fate of FLCs after birth; FLC: fetal Leydig cell, AFLC: adult 
fetal Leydig cell, PLC: progenitor Leydig cell 
 
There are several theories about the developmental fate of the FLCs. It was 
suggested that they undergo degeneration [48], dedifferentiate towards fibroblastic 
cells [52],  persist as a second Leydig cell type along with ALCs [53, 54] or re-
differentiate and give rise to the adult Leydig cell lineage [55]. Figure 5 gives a 
tentative model of the FLC fate.  
 
1.3.2 Development of the adult Leydig cell lineage 
 
 
Figure 6: Leydig cell development from putative stem Leydig cell (PSLC) to progenitor (PLC), 
immature (ILC) and mature adult Leydig cell (ALC) 
 
The development of the adult Leydig cell lineage begins in rodents after birth and in 
humans after the quiescent childhood period with the onset of puberty. Putative stem 
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Leydig cells (PSLCs) give rise to a progenitor cell type (PLCs) that further 
differentiates into immature Leydig cells (ILCs) followed by their maturation into adult 
Leydig cells (ALCs) (Figure 6). Testosterone production by mature LCs is required 
for the onset of spermatogenesis [29]. 
Several factors have been described to be involved in differentiation (e.g. LH, Dhh, 
PDGF-A [56] and cAMP) and in proliferation (e.g. LIF, PDGF, LH [56]  and cAMP) of 
ALCs. 
In contrast to fetal Leydig cells, adult Leydig cell differentiation is LH dependent. In 
LHR-knock out mice the total number of Leydig cells is reduced and androgens 
levels are undetectable [46]. 
The adult Leydig cells are responsible for androgen production during the adult 
lifespan. However, aging causes testosterone levels to decline about 50% [29]. 
 
1.3.3 Stem Leydig cell (SLC) 
 
Figure 7: Schematic overview of a putative stem Leydig cell; a mesenchymal-like cell with slender 
cytoplasm and elongated nucleus, long cytoplasmatic processes; grey receptor: PDGFRα 
 
Stem Leydig cells have a mesenchymal-like phenotype [12]. Morphological studies 
have shown that peritubular mesenchymal cells located in the outermost line of the 
peritubular compartment can give rise to the adult Leydig cell lineage [12, 55, 57, 
58].   
At the same time, vascular smooth muscle cells and pericytes of testicular blood 
vessels have also been proposed as possible precursor of ALCs [16], resulting in 
the hypothesis of a multifocal origin of Leydig cell precursors in neonatal testis [49, 
59, 60]. 
At day 7, spindle-shaped LHR- and 3βHSD-negative cells are found in the 
peritubular region of the neonatal rat testis (Figure 7). These cells express PDGFRα, 
LIFR and c-kit [1]. After their enrichment via PDGFRα their capacity for self-renewal, 
differentiation in vitro and replenishment of the peritubular niche in vivo has been 
demonstrated [1]. 
The PDGFRα has been shown to be expressed at all stages of Leydig cell 
development with a peak in the low differentiated progenitor Leydig cell population 
[61] and in neonatal peritubular cells [62].  
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PDGF-A-deficient mice do not develop the adult Leydig cell lineage [63], 
suggesting that PDGFRα plays an important role in the development of these 
testicular cells. 
 
1.3.4 Progenitor Leydig cell (PLC) 
 
 
Figure 8: Schematic overview of a progenitor Leydig cell; showing the typical spindle shape, the 
nucleus with nucleoli, some lipid droplets (grey) and a mitochondrium 
Prior to day 10 in rats, the stem Leydig cells are committed to the Leydig cell lineage 
and differentiate towards progenitor cells. These mesenchymal-like fibroblasts [12, 
59] are found in the outer layer of the seminiferous tubules and perivascular in the 
rat testis between day 11-28 and before three years of age in humans. 
PLCs still resemble the elongated and spindle-shape of stem cells, but they contain 
mitochondria and lipid droplets that are typical organelles of steroid producing cells 
(Figure 8). PDGFRα, LIFR and c-kit expression is still present [35], but in contrast to 
the stem cells, PLCs also express the steroidogenic enzymes P450scc, 3 βHSD, 
P450c17, 3αHSD, 17βHSD, as well as a truncated form of LHR and AR [12, 59, 64]. 
They produce androsterone as their endpoint steroid [65]. Progenitor Leydig cells 
are highly proliferative with a peak quantity at day 13 [66]. 
 
1.3.5 Immature Leydig cell (ILC) 
 
 
Figure 9: Schematic overview of an immature Leydig cell; the shape is rounder, the cell contains a 
nucleus with nucleolus, numerous lipid droplets, smooth endoplasmatic reticulum and mitochondria 
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From day 28-56 in rats, and between 3-8 years in humans [12, 67], immature Leydig 
cells are the most prominent Leydig cell type in the testis. The phenotype of these 
cells is rounder and they contain numerous lipid droplets (Figure 9).  
ILCs express high levels of testosterone metabolizing enzymes (e.g. 5α reductase II 
and 3αHSD) that convert testosterone into its metabolites, with 5α-androstane-
3α,17β-diol as the main steroid [35]. 
The ILCs move from the peritubular and perivascular region towards the interstitium 
[57], where they further mature into adult Leydig cells. 
 
1.3.6 Adult Leydig cell (ALC) 
 
 
Figure 10: Schematic overview of an adult Leydig cell; the round cell contains a nucleus with 
nucleolus, fewer lipid droplets, smooth endoplasmatic reticulum and mitochondria 
From 9-11 years in humans, ILCs start to mature [68] and with 15 years (day 56 in 
rats) [69], the maturation of the Leydig cell lineage has come to an end, making 
mature adult Leydig cells the dominant Leydig cell in the testis.  
Fully differentiated adult Leydig cells have a very limited capacity to proliferate [70]. 
However, cell regeneration after elimination with ethane-1,2-dimethyl sulphonate 
(EDS)  is possible [71]. 
ALCs are round in shape and contain smooth endoplasmatic reticulum (SER), few 
lipid droplets and mitochondria (Figure 10).  
In humans, subunits of globular proteins with an unknown function called  Reinke 
crystals are found in adult Leydig cells [35, 68]. 
ALCs express all steroidogenic enzymes. They produce testosterone as the main 
steroid and Insl3. Classical markers for LC identification are LHR and Insl3. 
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1.4  PERITUBULAR CELL (PTC, TPC) 
 
 
Figure 11: Schematic overview of a peritubular cell; slender cytoplasm with elongated nucleus, long 
cytoplasmatic processes 
 
Peritubular cells are smooth muscular cells surrounding the seminiferous tubule 
(Figure 11). In rodents, PTCs form a single layer around the tubules, whereas 
several cell layers with different phenotypes are found in humans [72]. Cells of the 
inner layer have more muscular characteristics and express desmin as typical 
marker. Towards the outer layer PTCs increasingly express vimentin and resemble 
more and more connective tissue cells [73]. 
For a long time, the endothelin-controlled tubule contraction- for sperm transport to 
the rete testis- was considered to be the most important function of PTCs [28, 74-
76]. However, recently, it has become evident that PTCs play additional roles in 
male fertility [77].  
As Sertoli cells, they secrete paracrine factors and ECM proteins [72, 78-81] and 
contribute to the spermatogonial stem cell niche [72, 80, 82]. 
The secretome of PTCs has been shown to contain fibronectin, collagen1, collagen 
4, laminin, nexin and cystein [82, 83].  
Classical markers for PTCs are α-SMA [84, 85] and Myh11 [79] (targeting their 
muscular characteristics), CD90/Thy-1 (their fibroblast property), [83] and alkaline 
phosphatase [86]. 
Testicular size is determined by PTC proliferation in the longitudinal growth of 
seminiferous tubules [77]. Their proliferation coincides with that of Sertoli cells and 
ceases before puberty. Sertoli cells help to maintain the PTC phenotype during 
prepubertal development [9]. During puberty, the peritubular cells mature, and 
cytoarchitectural changes such as flattening of the cells lead to an increase in the 
peritubular surface [87]. 
Already during fetal life, peritubular cells express AR, which is used by androgens to 
induce smooth muscle characteristics [88]. PTC- specific AR depletion causes 
infertility and a reduced testicular size in mice [76].  
Besides AR, PTCs also express PDGFRα and PDGFRβ [62, 81]. The PDGF 
signaling is involved in the regulation of the contractility. Stimulation of PTCs with 
PDGF causes their hypertrophy [89, 90]. 
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Expression of PDGFRα, an established stem Leydig cell marker [1]-, and 
morphological studies suggest that PTCs could be precursors for the ALC lineage 
[12, 57, 91].  
In addition, PTCs express functional receptors for histamine and tryptase [83] and 
are activated by mast cells. In infertile men, phenotypic changes of the PTCs have 
been described. In these cases, PTCs produced higher amounts of ECM 
components, causing fibrosis [72, 83].  
 
1.5 PLATELET-DERIVED GROWTH FACTOR RECEPTOR ALPHA (PDGFRA) 
The PDGF receptor α has been described as an important marker for the adult 
Leydig cell lineage [1, 92] and has subsequently been used to isolate stem Leydig 
cells from prepubertal rat testes [1]. 
PDGF receptors play a well-characterized role in proliferation and migration of 
mesenchymal cell types [8]. While the PDGFRβ solely binds to PDGF-B, the 
PDGFRα has a broader spectrum and binds PDGF-A, PDGF-B and PDGF-C as well 
as AB heterodimers [93-95]. 
PTCs and Leydig cells at all developmental stages express the PDGFRα [1, 61, 
62, 92]. While PDGF-A-deficient mice lack the adult Leydig cell lineage [63], a 
PDGFRα-knock-out leads to a smaller number of fetal LCs [8]. Taken together, 
these findings suggest that the PDGF signaling plays an important role in LC 
development. 
 
1.6 CAMP-PKA-PATHWAY 
The cAMP-PKA pathway plays an important role for Leydig cell function and is 
involved in the regulation of steroidogenesis (Figure 3), metabolism, gene activity, 
cell growth and division, differentiation, sperm motility as well as ion channel 
conductivity [96]. 
The cAMP-PKA pathway is a G protein-coupled receptor (GPCR)-triggered signaling 
cascade. Upon stimulation the activated Gs alpha subunit binds to and triggers the 
enzyme adenylyl cyclase, which converts ATP into cyclic adenosine 
monophosphate (cAMP). The second-messenger cAMP stimulates PKA, which, in 
turn, phosphorylates transcription factors and thereby regulates protein expression. 
LH, FSH and ACTH signal through GPCRs to activate steroidogenesis. These 
signals up-regulate StAR expression and activate the cholesterol ester hydrolase, 
which increases intracellular cholesterol levels [97, 98]. Furthermore, the cAMP-PKA 
signaling is involved in the up-regulation of mRNAs encoding steroidogenic enzymes 
[99, 100].  
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To simulate the adenylate cyclase activation through PKA signaling, cells can be 
treated with exogenous cAMP. (Bu)2cAMP, a metabolite of cAMP with two additional 
butyryl groups, can bypass the LHR, and raise intracellular cAMP levels in cells 
without a functional LHR (Figure 3). 
Forskolin activates the adenylate cyclase and thereby enhances cAMP production 
(Figure 3). 
 
1.7 HUMAN EMBRYONIC STEM CELL (HESC) 
1.7.1 Embryogenesis 
 
Figure 12: Schematic overview of embryogenesis; cells and tissues mentioned in more detail in the 
thesis are marked in blue 
 
 
Embryogenesis describes the development of the embryo until gastrulation [101]. It 
begins with the formation of a zygote when the spermatozoon and the oocyte 
combine. 
In the zygote, the cells undergo mitotic divisions. When the eight cell stage is 
reached, the zygote is called blastomere and develops further into the morula at the 
16-cell stage. The morula is divided into two layers, an inner non-polarized and an 
outer polarized layer. 
Subsequently, the blastocyst formation starts, and a fluid-filled cavity called 
blastocoel develops. In humans, this stage is reached five days post fertilization.  
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The two layers of the blastocyst develop further into the inner cell mass (ICM), 
formed from the non-polarized cells, and the trophoblast layer, formed from the 
polarized cells (Figure 12). 
The ICM then gives rise to extra-embryonic membranes and the embryo, while the 
trophoblast layer differentiates into the embryonic part of the placenta (chorion) and 
the mesodermal cells. 
The placenta consists of the chorion and the maternal part, the decidua. During 
pregnancy, the placenta is used as nutrition source and waste disposal. 
Furthermore, it plays an important role as an immune-rejection block. 
The blastocyst enters the uterus and starts to produce plasmin, which degrades the 
zona pelucida and thereby facilitates the hatching of the blastocyst into the uterus 
wall. At that point, the ICM has formed a bilaminar disc containing a hypo- and an 
epiblast.  
The hypoblast develops further into the extra-embryonic endoderm and forms the 
yolk sac, while the epiblast differentiates into the amniotic endoderm and the 
embryonic epiblast. 
The amniotic endoderm builds the amniotic sac, which is filled with amniotic fluid and 
contains the embryo. 
The embryo is formed out of the embryonic epiblast that differentiates into the three 
germ layers and germline cells [102]. During gastrulation, the primitive streak and the 
three germ layers emerge. The germ layers will give rise to the differentiated organs. 
The mesoderm forms e.g. the skeleton, the skeletal muscles, the heart, the coelomic 
epithelium and the gonad somatic cells as well as the testicular interstitial cells. The 
ectoderm further differentiates into e.g. the nervous system, the epidermis and the 
lens of the eyes. The endoderm will develop into e.g. the stomach, the liver and the 
epithelial parts of the trachea. 
Primordial germ cells are the germ cell precursors that transfer the genetic 
information from one generation to the next. They migrate from the yolk sac wall into 
the genital ridge to further differentiate into gonocytes. In humans, this happens 4-6 
weeks after gestation [102].  
While in females gonocytes become meiotic oocytes, in males gonocytes undergo 
mitotic arrest and become quiescent prespermatogonia that restore meiosis after 
birth. 
 
1.7.2 Embryonic stem cell (ESC) 
Human embryonic stem (hES) cells are of great potential use in regenerative 
medicine. They serve as an important tool in human disease modelling, drug 
discovery [103] and the study of differentiation pathways. 
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The first mouse ES cells were isolated in 1981 from 4-5 day old mouse embryos by 
Evans and Kaufman [104]. Several years later in 1984, Fishel and Edwards 
achieved the first isolation of hES cells [105], but not until 1994 the first hES cell line 
was cultured by Bongso [106]. 
hES cells are derived from the inner cell mass of a human blastocyst at day 5-8 after 
fertilization [107, 108] or from 8-cell stage embryos [109].  
These pluripotent cells have the potential to differentiate into all three germ layers 
and germ line cells in vivo as well as in vitro. ES cells have the capacity for self-
renewal and express pluripotency markers (e.g. Pou5f1, Nanog, the stage specific 
embryonic antigen [SSEA4], the tumor related antigen [Tra1-60] and Sox-2). After 
transplantation into immunodeficient (SCID) mice, they form teratomas. 
In serum free conditions, self-renewal depends on FGF2 [110], whereas 
differentiation is induced BMP stimulation [111]. 
To date standard culture conditions for hES cells require fetal mouse or human 
foreskin fibroblasts [107, 112], but defined xeno- and feeder-free systems are 
needed for hES cells to avoid problems with immunogenicity, microbial or viral 
contamination, and variability [113]. 
 
1.7.3 Laminin (LN) 
The classical feeder-free culturing system uses matrigel, a protein mixture derived 
from mouse Engelbreth-Holm-Swarm tumors [103] that contains LN111, type IV 
collagen, perlecan and nidogen, growth factors and several unknown components 
[113]. The batch-to-batch variability creates problems for the comparability between 
hES cell experiments. 
To use ECM proteins as matrix instead of matrigel has several advantages. These 
proteins are part of in vivo niches of stem cells and facilitate differentiation, 
phenotype maintenance, adhesion, function of many cell types, proliferation, 
migration and self-renewal [113].  
Laminin is an important component of basement membranes [113] and the most 
dominant component of matrigel [103]. It binds to receptors on cell surfaces, e.g. 
integrins, which are major adhesion receptors of hES cells [114]. 
Laminins build a family of heterotrimeric glycoproteins, containing α, β and γ chains. 
For example laminin 521, used in this work, consists of an α5, β2 and γ1 chain [115]. 
It is expressed by the ICM and hES cells, in hair follicles and in intestinal villus crypts 
[115]. 
On laminin, hES cells grow as a monolayer. The cells acquire a migration potential 
without differentiation that is beneficial for hES cell culturing. A second advantage of 
the monolayer formation is the increased cell accessibility, which facilitates a more 
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homogenous distribution of differentiation factors [113] and enhances the 
differentiation process. 
 
1.7.4 Steroidogenic Factor 1 (SF-1) 
 
 
Figure 13: Role of SF-1 during male sexual differentiation, SF-1 function shown in blue 
 
The steroidogenic factor 1 is involved in male sexual differentiation by determination 
of fetal Leydig and Sertoli cell function (Figure 13). 
In addition, it has been described to facilitate steroidogenic cell differentiation of 
pluripotent cells [116-118].  
SF-1 belongs to the nuclear hormone receptor family (NR5A), a group of gene-
specific transcription factors involved in the formation of steroid hormones, thyroid 
hormone, vitamin D and retinoids [119]. 
SF-1 is a cell-selective orphan nuclear receptor and a key regulator of endocrine 
function in hypothalamic-pituitary-gonadal axis and sex differentiation [119].  
It is expressed in the urogenital ridge, all three layers of the adrenal cortex, Leydig 
and Sertoli cells, ovarian granulosa and theca cells, the placenta, the pituitary and 
the hypothalamus [120]. 
Monomeric SF-1 binds to the responsive element located in promoter regions of 
different steroidogenic enzymes and enhances their transcription [119]. SF-1 is 
involved in the regulation of the expression of the steroidogenic enzymes P450scc, 
P450c17, 3βHSD and aromatase [119, 120] in the regulation of StAR, LHR, AMH 
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and SRY [121, 122]. The cAMP-PKA pathway can enhance SF-1 transactivation 
activity, on target genes such as CYP11A1 and STAR [123]. 
SF-1 deficiency leads to a lack of adrenal glands and gonads, a male-to-female sex 
reversal of internal and external genitalia, and death due to adrenocortical 
insufficiency [124].  
The Liver Receptor Homologue 1 (LRH-1) is closely related to SF-1. However, it is 
encoded by a different gene and also expressed in the liver and pancreas [119, 125]. 
Both, SF-1 and LRH-1, regulate Oct3/4 expression and can therefore induce 
pluripotency in somatic cells [126-128]. 
 
1.7.5 In vitro derivation of steroidogenic cells 
To learn more about early differentiation pathways involved in the development of 
Leydig cells, several groups have used in vitro derivation of steroidogenic cells from 
mouse and human embryonic and mesenchymal stem cells.  
So far, only overexpression of SF-1 or LRH-1, respectively, has led to steroidogenic 
cell differentiation through alteration of chromosomal structures [116-118, 127, 129-
132]. 
Crawford et al. ectopically expressed SF-1 in mES cells and found progesterone 
producing cells upon the addition of 20α-hydroxycholesterol, a substrate for 
steroidogenesis that is able to bypass the outer mitochondrial membrane. The 
derived cells were shown to express endogenous CYP11A1, and the expression 
was increased through cAMP/RA treatment [116]. 
Gondo et al. transfected mouse bone marrow and mesenchymal stem cells derived 
from adipose tissue with SF-1 and described the development of ACTH responsive 
cells that expressed genes for steroidogenic enzymes and produced testosterone. 
They found that adipose derived cells were more similar to adrenal cells, while the 
bone marrow derived cells showed a more gonadal phenotype [117, 130].  
Also Jadhav et al. has worked with murine cells. They transfected mES cells to 
overexpress SF-1 and obtained progesterone secreting cells. LIF removal for 7d 
followed by cAMP stimulation for 4d further differentiated these cells towards 
testosterone and estradiol production as well as de novo cholesterol synthesis. 
Most studies involving material of human origin use bone marrow derived 
mesenchymal cells. Tanaka et al. overexpressed SF-1 in human bone marrow cells 
and detected ACTHR and LHR expression as well as testosterone production in the 
differentiated cells [118]. 
As a complementary approach, overexpression of LRH1, another member of the 
nuclear hormone receptor family (NR5A), was compared to SF-1 by Yazawa et al. 
Overexpression of both LRH-1 and SF-1 in human MSCs followed by cAMP 
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stimulation led to steroidogenic enzyme expression and steroid production in the 
cells. To be able to differentiate hES cells into steroidogenic cells, the cells were first 
pre-differentiated towards the mesenchymal cell line before overexpression of SF-1 
induced steroidogenic cell formation [131, 133, 134]. 
Sonoyama et al. were able to show that SF-1 transfection followed by treatment with 
cAMP for 7-14 days differentiated hES and hIPS cells into adrenocortical cells, while 
differentiation of hES cells through embryoid body formation resulted in trophoblast 
like cells [129]. 
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2 PROJECT AIMS 
The general aim of this thesis was to gain more knowledge about the 
development of Leydig cells. The phenotype and the possible relationship of 
rat and human peritubular cells with the adult Leydig cell lineage were 
analyzed. Furthermore, the potential of human embryonic stem cells to 
differentiate into steroid-producing cells was evaluated. 
 
The specific aims of the four projects were: 
 
1) To analyze the phenotype, steroidogenesis and proliferative activity                                      
of postnatal fetal Leydig cells.  
2) To characterize PDGFRα-positive peritubular cells in neonatal rat 
testes and to explore their potential to differentiate into the adult 
Leydig cell lineage. 
3) To describe PDGFRα-positive human testicular peritubular cells and 
to examine their potential for differentiation into the adult Leydig cell 
lineage. 
4) To screen different hES cell lines for their differentiation potential    
towards gonadal cell types. 
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3 METHODOLOGY 
3.1 ETHICS 
All studies were performed with permission from an Ethical Board. For Project 1 and 
2, “Stockholms Norra Djurförsöksetiska Nämnd” approved the animal experiments 
(N319/08, N143/08, N305/09, N489/11). Project 3 was performed under the ethical 
permission of the “Ethikkomission der Fakultät für Medizin der Technischen 
Universität München” (3051/11) and Project 4 was authorized through the 
“Forskningsetikkommitté Syd” (454/02).  
All efforts were taken to minimize suffering of animals and patients. 
 
3.2 CELL CULTURE 
Cultivation of freshly isolated cells and cell lines was a key part of all projects in this 
thesis. 
In Project 1 and 2, cells were freshly isolated from rat testicular tissue and kept in 
culture for up to one week. All cell cultures are to some degree artificial systems that 
affect cell behavior through the in vitro culture conditions, but primary cell cultures 
resemble the in vivo situation more closely than cell lines. However, the need of a 
constant animal supply for their creation is an important draw back and experimental 
reproducibility relies heavily on the repeatable recreation of cell cultures derived from 
different animals. 
In Project 3, cells were derived from human testicular biopsies but kept in culture for 
several passages and are therefore more similar to cell lines. In Project 4, seven 
human embryonic cell lines were used.  
From an ethical point of view, the use of cell lines is preferable. Higher reliability and 
reproducibility of the experiments are clear advantages, but the artificial culture 
conditions may change cell behavior substantially and limit the transferability of the 
results to the in vivo situation. 
 
3.2.1 Rat fetal Leydig cells and peritubular cells (Paper I & II) 
Postnatal fetal Leydig cells and peritubular cells were isolated from 7-8 day old male 
SD-rat pups housed under standard conditions in the animal facility of Karolinska 
Institutet. 
After decapitation of the pups, the testes were decised and decapsulated. The tissue 
was mechanically and enzymatically disintegrated and the interstitial cells were 
separated by filtration and centrifugation. 
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To isolate the FLCs, the cell preparation was incubated with an antibody against 
LHR, an established Leydig cell marker, and a magnetic cell separation technique 
(MACS) was used for purification.   
In Project 2, testicular cell suspensions depleted of fetal Leydig cells were used to 
isolate PDGFRα-peritubular cells using the MACS technology. The isolated cells 
were LHR-negative and PDGFRα-positive. This expression profile has previously 
been described for putative stem Leydig cells [1]. 
In both projects, the isolated cells were transferred into DMEM+F12 containing 2% 
FCS and cultured at 34 ̊ C and 5% CO2. After stimulation with different factors like 
(Bu)2cAMP, hCG, PDGF-A and LIF for up to 72 hours the cells were analyzed for 
their proliferation- and differentiation-potential as well as their capacity for steroid 
production in vitro. 
 
3.2.2 Human testicular peritubular cells (Paper III) 
Human testicular peritubular cells (HTPCs) that were used in Project 3 were isolated 
by outgrow culture from testicular biopsies from patients with obstructive and non-
obstructive azoospermia. Biopsies were routinely taken prior to relegation of the vas 
deferens or intracytoplasmatic sperm injection treatment.  
Patients suffering from obstructive azoospermia have a post testicular blockage of 
the sperm delivery but normal spermatogenesis, while non-obstructive azoospermia 
is caused by testicular sperm production failure. 
After isolation, the HTPCs were cultured in DMEM with phenol red, a high 
concentration of glucose (4.5g/l), L-glutamine and 10% FCS for 5-10 passages prior 
to experiments. 
To stimulate proliferation, differentiation and steroid production, the cells were 
treated with forskolin or PDGF-B for 6 to 24 hours. 
 
3.2.3 Human embryonic stem cells (Paper IV) 
Human embryonic stem cells (hESCs) originate from the inner cell mass of a human 
blastocyst at 5-8 days after fertilization. All seven cell lines were derived from the 
group of Prof. Outi Hovatta at the Karolinska Institutet in Huddinge. 
Before the start of the project, hES cells were cultured on human foreskin fibroblasts 
for 17-40 passages. For Project 4, all cell lines were thawed and cultured in wells 
coated with human recombinant laminin 521 in NutriStem for 4-5 passages before 
characterization. 
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3.3 CELL PROLIFERATION 
3.3.1 3H-Thymidine incorporation (Paper I) 
To measure cell proliferation, cells were incubated for 24 hours with radioactively 
labeled thymidine, which is incorporated into the DNA of dividing cells. The read-out 
gives the amount of radioactively marked cells actively proliferating during the 
incubation period. The cells were stimulated with (Bu)2cAMP, PDGF-A, LIF and their 
combinations for 72 hours prior to incubation with labeled thymidine and compared 
to untreated controls. 
 
3.4 PROTEIN EXPRESSION 
3.4.1 Immunohisto- and Immunocytochemistry (Paper I-IV) 
Immunohistochemistry (IHC) uses specific antibodies to identify, localize and to 
some extent quantify protein expression in cells or tissues. The procedure was first 
published by Dr. Albert Coons in 1942 and improved in 1950 [135]. 
Depending on the fixation and staining methods used, IHC provides information 
about protein expression in specific cell types in tissue samples, the morphology of 
the tissue, as well as co-localization of different proteins.  
To visualize an antigen-antibody interaction between a target and a primary 
antibody, two different standard methods are used. A secondary antibody 
conjugated with peroxidase, streptavidin or biotin can bind and oxidize 3,3'-
Diaminobenzidine (DAB), producing a brown color in the vicinity of the target protein. 
Secondary antibodies bound to a fluorescent dye are used especially for the analysis 
of co-expression. By using different dyes detectable at different wave lengths the 
expression of several proteins can be monitored in the same sample. 
To control for the specificity of the primary antibody, samples of tissues or cells with 
known expression patterns can be used as a positive control. Samples treated with 
unspecific IgGs produced from the same species as the primary antibody are used 
as controls for unspecific background staining. 
 
3.4.2 Western Immunoblot (Paper I & III) 
Western Immunoblot is a standard method used to identify and quantify proteins. In 
contrast to IHC, the result does not provide any information about the localization.  
The method was developed in the laboratory of Harry Towbin in 1979 [136]. It is a 
semiquantitative method that can be applied for the detection of proteins in cell and 
tissue samples. 
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In a first step, the cells are lyated and the proteins denaturated. The denaturated 
proteins are separated according to their molecular size on a SDS-polyacrylamid gel 
and transferred to a membrane, which is subsequently stained for immunodetection.  
Several controls are routinely included in the procedure. A mixture of standard 
protein with known molecular weights is added to the SDS-gel to determine the size 
of the immunostained protein. Staining of a reference house-keeping protein verifies 
equal loading of samples. A sample where the protein is known to be expressed, can 
be used as a positive control to confirm the specificity of the antibody. 
To quantify protein expression, the density of the bands is determined and assessed 
relative to the house-keeping protein.  
 
3.5 GENE EXPRESSION 
3.5.1 RT-PCR (Paper I-III) 
Reverse transcriptase polymerase chain reaction (RT-PCR) is a standard method to 
detect and, to some degree quantify gene expression in cell- or tissue samples by in 
vitro amplification of cDNA fragments. RT-PCR was developed in 1987 by Kary 
Mullis, who earlier discovered Taq polymerase, the prerequisite for PCR 
development [137]. 
A PCR cycle is divided into three steps. First the sample is heated to 96 ̊ C to 
denaturate the DNA strands, then the temperature drops to around 60 ̊ C to allow 
specific primers to bind and initiate elongation of the complementary strand. The 
temperature is then raised again to 72 ̊ C, which allows the Taq polymerase to 
synthesize the new DNA strand.  This cycle is repeated for up to 40 times, which 
leads to an exponential increase in the copy number of the amplified cDNA 
fragment. 
To verify the efficiency of the PCR and the specificity of the primer pairs, several 
control reactions are required. The expression of a house-keeping gene (e.g. β-actin 
or GAPDH) is determined for each sample to check for equal cDNA concentrations. 
A tissue or cell type sample with known gene expression level should be included as 
a positive control, and reaction samples prepared without reverse transcriptase can 
be used as negative controls to exclude amplification of chromosomal DNA. Primer 
specificity can be controlled by determination of the PCR product size on an agarose 
gel. 
 
3.5.2 Q-PCR (Paper I-IV) 
In addition to detection of gene expression, quantitative polymerase chain reaction 
(qPCR) measures cDNA production in real-time and can be used to compare the 
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gene expression between different groups, e.g. before and after treatment, or in 
different cell types or tissues, respectively. 
The gene expression is normalized to the expression of a house-keeping gene and 
quantified with a standard curve, as done in Project 1+2, or calculated with the 
comparative Ct method after Livak as done in Project 3+4 [138].  
Experiments described in this thesis work used Sybr Green, a dye that binds to 
double-stranded DNA to detect amplified cDNA strands. 
Similar to RT-PCR, tissues or cells can be used as positive controls and cDNA 
produced without reverse transcriptase as controls to exclude chromosomal DNA 
amplification. To verify the specificity of the primer, the product size is checked by 
agarose gel electrophoresis. 
 
3.5.3 TLDA (Paper IV) 
The TaqMan low density array (TLDA) uses quantitative PCR to measure gene 
expression. It is based on the exonuclease assay TaqMan [139]. Briefly, the probes 
that consist of a fluorophore bound to the 5’-end of an oligonucleotide and a 
quencher on the 3’-end, anneal with a specific DNA region. After amplification of the 
DNA strand, the polymerase activity degradates the quencher and allows the 
fluorescence of the fluorophore. 
In Project 4, microfluidic cards designed for stem cell research [140] that contained 
primers for 96 genes expressed in undifferentiated stem cells (NANOG, POU5F1, 
TDGFI, DNMT3B, GABRB3, GDF3), involved in maintenance of pluripotency 
(NANOG, POU5F1, SOX2) or early markers for differentiation, were employed. 
The gene expression is normalized to the mean of six house-keeping genes to 
control for comparability of results. 
 
3.6 STEROID PRODUCTION 
3.6.1 RIA (Paper I-III) 
The radio immune assay (RIA) is an immunological method to quantify 
protein/steroid production. The first RIA was developed by Rosalyn Yalow and Aaron 
Berson in 1960 to measure insulin in patient serum samples [141]. 
Radioactively labeled substrate and the samples are mixed in an antibody-coated 
tube. Competitive binding to the antibody between 125I -radiolabeled and the present 
analyte occurs. A standard curve based on known concentrations of substrate is 
used to determine the substrate concentration in the samples. 
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3.6.2 Steroidogenic enzyme activity assay (Paper I) 
To measure the enzyme activity, radioactively labeled steroids are added to the 
samples for 24 hours. After separation by thin-layer chromatography (TLC) the 
amount of the remaining substrate and the formed metabolites are quantified by 
scintillation counting. 
TLC sorts steroids by polarity, i.e. according to their OH-groups. The samples are 
applied to a silica-gel coated aluminium foil and eluated with a mobile phase 
containing chloroform and ethylacetat in 4:1 ratio. Capillary action causes upward 
migration of the analytes and migration velocity is proportional to analyte polarity. 
Samples can be detected with UV-light or after iodine exposure. The respective 
spots are cut out from the foil and their radioactivity measured by scintillation. 
 
3.6.3 Mass spectrometry (Paper III) 
Mass spectrometry (MS) measures the weight-to-charge ratio of molecules with high 
accuracy. A combination of liquid chromatography and MS can be used to determine 
the presence and identity of biological molecules such as, in this case, steroids.  
Briefly, the molecules in a sample solution are separated based on polarity by 
reverse phase chromatography, ionized and broken down by collision with argon 
gas. The resulting fragments are analyzed by MS, and characteristic fragmentation 
patterns are used to identify the steroids present in the sample. 
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4 RESULTS AND DISCUSSION 
4.1 CHARACTERIZATION OF POSTNATAL FETAL LEYDIG CELLS        
(PAPER I) 
To identify the stem Leydig cell, we first characterized the two steroidogenic cell 
types in the neonatal rat testis to elucidate the fate of fetal Leydig cells after birth and 
to characterize postnatal fetal Leydig cells (FLCs) according to their steroidogenic 
capacity in vitro. 
FLCs produce the androgens that are responsible for the masculinization of the fetus 
during its development. However, their fate after birth remains to be determined. It 
has been suggested that they can degenerate, dedifferentiate to fibroblastic cells, 
persist as second steroidogenic cell type in the testis or give rise to the adult Leydig 
cell lineage [48, 52-54].  
 
4.1.1 Phenotype of postnatal fetal Leydig cells 
To analyze the phenotype of the postnatal fetal Leydig cells, a protocol for magnetic 
cell separation (MACS) of FLCs for LHR was established. With about 98% LHR 
positive cells, the cell population was highly enriched. Furthermore, 97-98% of the 
cells expressed Leydig cell specific markers such as Insl3, LHR, 3βHSD and StAR, 
indicating that they are fully differentiated LCs (Figure 14). 
 
Figure 14: Expression of Leydig cell markers by FLCs; A: Insl-3, B: LHR, C: 3βHSD, D: StAR; nuclei 
are counterstained with DAPI. The corresponding negative controls are shown in the bottom corners. 
Size bar: 20µm 
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4.1.2 (Bu)2cAMP stimulates steroid production in PFLCs  
Isolated PFLCs maintained a transient capacity to produce testosterone in vitro. 
Unstimulated cells stopped to produce testosterone after 24 hours and all steroid 
production ceased after 72 hours. However, stimulation with hCG or (Bu)2cAMP 
prolonged and increased steroid production.  
During long-term culture FLCs stopped to express Leydig-cell related genes like 
3βHSD, P450c17 and Insl-3 and showed signs of dedifferentiation that were 
preventable by (Bu)2cAMP. 
(Bu)2cAMP treatment restored steroidogenic gene expression, but a Western Blot 
analysis revealed decreased functional protein expression of P450cyp17. Due to 
P450cyp17 suppression at the translational level, progesterone accumulated in the 
culture medium after 48 hours when testosterone production decreased.  
Treatment with PDGF-A and (Bu)2cAMP, individually or in combination stimulated 
FLC proliferation. 
The fate of the fetal Leydig cell generation has been widely discussed [48, 52-54]. 
The results of this study showed that immediately after birth, FLCs still possessed 
the capacity to produce steroids, but lost this ability in vitro within 72 hours. The 
expression of Leydig cell specific markers such as Insl-3 and LHR was severely 
attenuated, suggesting a process of dedifferentiation. Similar observations have 
been made in cultured hamster Leydig cells [142] and in dedifferentiated human LCs 
[143].  
However, stimulation with cAMP was able to rescue FLCs from dedifferentiation and 
induced proliferation, indicating that the cAMP-PKA pathway plays an important role 
in the regulation of steroidogenesis and mitotic activity in the FLCs. It had been 
shown previously that this pathway was involved in upregulation of genes encoding 
steroidogenic enzymes in mouse Leydig cells [99, 100]. 
PDGF-A stimulated FLC proliferation, a finding that is in accordance with previous 
studies, which had shown that PDGF-A signaling was active in FLCs [144], and 
PDGFRα-knock out studies, which showed significantly reduced FLC numbers [8].  
In summary, neonatal FLCs possessed a steroidogenic capacity, which was lost 
under in vitro conditions within 72 hours due to an attenuation of functional P450c17 
expression. This loss was partially rescued by cAMP stimulation. Both cAMP- and 
PDGF-signaling were involved in the proliferation of FLCs. 
 
4.2 IDENTIFICATION OF PUTATIVE STEM LEYDIG CELLS IN THE NEONATAL 
RAT TESTIS (PAPER II) 
Having identified the transient steroidogenic capacity of the postnatal fetal Leydig 
cells and its stimulation through cAMP and hCG, we investigated whether the 
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phenotype and the steroidogenic profile of the PDGFRα-positive putative stem 
Leydig cells exhibit similar characteristics. 
Several studies have suggested that the origin of the adult Leydig cell lineage is 
located in the peritubular compartment of the testis. The putative precursor cells 
have been described as spindle-shaped steroidogenic enzyme containing cells in the 
peritubular region [55, 57, 60, 145]. Gnessi et al. reported that neonatal peritubular 
cells express PDGFRα and that this receptor was otherwise restricted to the Leydig 
cell lineage within the testis [62]. In addition, Ge et al. reported stem Leydig cells in 
7-day old rat testes to be PDGFRα- and LIFR- positive, and LHR-negative. These 
cells have been described to possess a self-renewing capacity in long-term culture 
and began to express Leydig-cell related genes after cultivation in differentiation 
medium [1]. 
 
4.2.1 Phenotype of PDGFRα-positive peritubular cells  
Immunohistochemical staining of 7-day old rat testis sections revealed that 
peritubular cells (PTCs) co-express αSMA, a known peritubular cell marker, and 
PDGFRα, a receptor described to be expressed by stem Leydig cells (Figure 15, A-
C).  
A subpopulation of the PTCs also expressed LIFR, another stem Leydig cell marker, 
as well as StAR and P450scc, proteins involved in steroidogenesis, suggesting a 
relationship with the Leydig cell lineage.  
Thus, we isolated the PTC population, using the MACS technology described in 
Project 1, in order to further characterize the phenotype of these putative stem 
Leydig cells in regard to their relationship to the peritubular cell lineage and their 
steroidogenic capacity in vitro.  
To achieve a higher purity and prevent a contamination with fetal Leydig cells, a 
second, negative purification step was included. First, the cell suspension was 
depleted off LHR-positive fetal Leydig cells and then PDGFRα-positive cells were 
isolated. 
The isolated cells expressed both PDGFRα and αSMA and a subpopulation was 
also positive for LIFR, StAR and P450scc, a steroidogenic enzyme (Figure 15, D-F), 
indicating a potential steroidogenic capacity of the isolated PTCs.  
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Figure 15: 7day old rat testis and isolated PTCs stained for stem Leydig cell, peritubular and 
steroidogenic marker.  A: PDGFRα (green), B: αSMA (red), C: overlay, D: PDGFRα (red), E: P450scc 
(green), F: overlay. Nuclei are counter stained with DAPI. Negative controls are displayed in figure C, 
bottom left and figure F, top right respectively. 
 
To further characterize the phenotype of the isolated cells, their gene expression 
profile was analyzed using quantitative PCR. Gene expression for Nes, Pou5f1 
(markers for pluripotent cells), Lifr, Pdgfra (markers for stem Leydig cells), Myh11 
(marker for peritubular cells) and Nr5a1, Tspo and Star (markers for steroidogenic 
cells) was detected. Furthermore, low level gene expression was identified for genes 
encoding steroidogenic enzymes. Expression of markers for mature Leydig cells, 
such as Insl3 and Lhr, was negligible. Taken together, these findings indicated that 
these cells were in an early stage of LC development and confirmed that the cell 
population was not contaminated by FLCs. 
Radioimmuno assays showed that the PDGFRα-positive PTCs were able to produce 
very low levels of testosterone for one day and progesterone for five days. During 
longer culture periods, inactivation of P450c17 and 17βHSD occurred resulting in the 
accumulation of progesterone in the culture medium. 
 
4.2.2 (Bu)2cAMP stimulates steroid production in PTCs 
cAMP has been described to be involved in the regulation of steroidogenesis in 
mouse Leydig cells [99, 100] and plays an important role in fetal Leydig cell 
steroidogenesis as shown in Project 1 [146].  
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To explore whether the cAMP-PKA-pathway activates steroidogenesis in putative 
stem Leydig cells, the cells were grown in the presence and absence of (Bu)2cAMP 
for seven days.   
Stimulation with (Bu)2cAMP increased and prolonged steroid gene expression as 
well as steroid production in the PDGFRα-positive PTCs. It furthermore attenuated 
dedifferentiation towards the PTC phenotype as shown by down-regulation of the 
Myh11-expression.  
Taken together, these findings suggest that the neonatal PDGFRα-positive PTCS 
are possible precursors for the adult Leydig cell lineage. In these cells, the cAMP-
mediated signaling is involved in the regulation of steroidogenesis and preservation 
of the steroidogenic phenotype. 
 
4.3 HUMAN PERITUBULAR CELLS CONTAIN PUTATIVE STEM LEYDIG 
CELLS (PAPER III) 
In order to verify the transferability of the rodent data into humans, we subsequently 
analyzed the phenotype and the steroidogenic capacity of human peritubular cells 
(HTPCs). 
Earlier studies have suggested that fibroblastic cells in the tubular wall are a source 
of differentiated Leydig cells in humans [147, 148], and that these mesenchymal 
cells in the testes of prepubertal boys can be stimulated to produce testosterone 
[147].  
Electron microscopy analysis of the peritubular wall of infertile patients with 
cryptorchidism or Sertoli-cell syndrome has revealed the presence of mature Leydig 
cells [149]. In healthy tissue, differentiating Leydig cells are migrating into the 
interstitial space and are not found in the peritubular wall, but the authors reported 
the occasional presence of spindle shaped Leydig cells in between the peritubular 
layers [149].  
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4.3.1 Characterization of human testicular peritubular cells 
 
 
Figure 16: Adult human testis and isolated HTPC stained for peritubular, stem Leydig cell and 
pluripotency markers. In the testicular sections the HTPCs co-express αSMA (A) and PDGFRα (B). 
An overlay of αSMA and PDGFRα is shown in (C). Isolated HTPCs stained for Nanog (D) and 
PDGFRα (E) with an overlay (F). Negative controls are displayed in the upper right corners of A and 
D, respectively. 
 
In the testis of infertile men, StAR positive cells were found in the peritubular 
compartment and electron microscopy showed immature Leydig-like cells containing 
lipid droplets and smooth endoplasmatic reticulum within the peritubular wall. These 
results led to the hypothesis that the HTPCs could be related to the Leydig cell 
lineage and possibly be stimulated to become steroidogenic. 
Immunohistochemical staining revealed that there are HTPCs that co-express αSMA 
and PDGFRα (Figure 16, A-C), showing the same expression pattern that was found 
in PTCs from neonatal rat testes [150].   
To further characterize this cell population, HPTCs were isolated from human 
testicular biopsies from adult men with obstructive and non-obstructive azoospermia. 
These explant cultures provided a unique in vitro model to examine various aspects 
of HTPCs. The isolated cells were found to express αSMA, a marker for peritubular 
cells, and PDGFRα, typical for putative stem Leydig cells. The cells stained 
positively for StAR, which may suggest a steroidogenic capacity. Nanog expression 
was found in the cytoplasm, which indicates pluripotent qualities (Figure 16, D-F).  
The gene expression profile analyzed by RT-PCR confirmed the expression of 
markers for pluripotency, stem Leydig cells, steroidogenesis, as well as 
steroidogenic enzymes. No mature LC markers such as LHR and INSL3 were found. 
Stimulation with PDGF-B confirmed the functionality of the PDGFRα and increased 
the STAR expression. Therefore, PDGF-signaling seems to play a role in the 
regulation of the steroidogenic phenotype. 
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4.3.2 Forskolin stimulates steroid production in HTPCs 
Forskolin is known to activate adenylate cyclase to enhance the cAMP production 
and activate the cAMP-PKA signaling pathway. Forskolin stimulation of the HTPCs 
led to an increase in the expression of STAR and CYP11A1 as well as promotion of 
steroid production. This indicated that the cAMP-PKA pathway was involved in 
steroidogenesis in the human PTCs. 
Taken together, the results of Project 3 suggest that HTPCs may be related to the 
adult Leydig cell lineage in humans. They possess pluripotent and steroidogenic 
capacities, and their steroidogenic phenotype is upregulated through cAMP-PKA 
signaling. 
 
4.4 IDENTIFICATION OF HES CELL LINES WITH STEROIDOGENIC 
DIFFERENTIATION POTENTIAL (PAPER IV) 
Human embryonic stem cell lines are a suitable tool for the study early differentiation 
processes. Therefore, we characterized seven different male hES cell lines (HS207, 
HS360, HS361, HS364, HS380, HS401 and HS420, derived at the Karolinska 
Institutet, Huddinge) with regard to their differentiation potential towards gonadal cell 
lines to identify possible candidates for steroidogenic cell differentiation. 
Human embryonic stem cells (hES cells) are an important tool in the field of 
regenerative medicine. They have the capacity for self-renewal and can differentiate 
into all three germ layers. Recent studies have shown that hES cell lines differ in 
their expression profile and seem to have preferred differentiation pathways [151-
153]. 
Typically, ESCs are cultured on feeder cells that help to maintain the stem cell 
capacity of the ESCs [112]. However, for purposes related to regenerative medicine, 
xeno- and feeder-free culturing conditions are needed [113, 115].  
 
4.4.1 Characterization of seven human embryonic stem cell lines with regard 
to their differentiation potential towards gonadal cells 
The hES cells were cultured on human recombinant laminin 521-coated wells. 
Laminin is a component of the natural hES cell niche and has been shown to support 
preservation of hESCs pluripotency and self-renew capacity [113]. Unlike feeder 
supported culture conditions, where ES cells grow in colonies, cells on laminin-
coated surfaces spread out and form a monolayer (Figure 17). 
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Figure 17: hES cell lines cultured on recombinant human laminin 521, size bar: 100µm 
 
After 4-5 passages on laminin, the phenotype and the expression profile of the 
seven hES cell lines were analyzed. All seven cell lines had a normal male 
karyotype and expressed pluripotency markers on the mRNA and protein level 
(Figure 18). 
TLDA analysis revealed differences in the expression patterns of all seven cell lines. 
While the expression of the house keeping genes was comparable between the 
samples and all seven hES cell lines still expressed the main pluripotency markers, 
they differed in their expression of differentiation related genes. 
 
Figure 18: HS360 after five passages on LN521 expresses pluripotency marker Pou5f1, Nanog, 
SSEA4 and Tra1-60, size bar: 20µm 
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For the purpose of this study, we focused on genes that are involved in 
differentiation towards gonadal cell lines. As markers for germ cell development, the 
expression of SOX2, NODAL, SYCP3, KIT and DDX4 was taken into account. There 
was no cell line that expressed significantly higher levels of these genes. To identify 
a capacity to differentiate towards the Sertoli cell lineage, the expression of Sertoli 
cell related genes was analyzed, i.e. SOX17, GATA6, SOX9, FSHR, SCF, GATA4, 
AR and WT1. Besides AR, all other genes were upregulated in HS361, suggesting 
that this cell line contained more cells with Sertoli cell-like characteristics than the 
other cell lines. 
The expression of different steroidogenic cell markers, e.g. NR5A1, NR5A2, STAR, 
CYP11A1 and HSD3B, was measured to detect cell lines with the capacity to 
become steroidogenic cells. HS420 contained cells that expressed higher levels of 
some of NR5A1 and HSD3B.  
To further distinguish between the different steroidogenic cell types, the expression 
of HCGB was analysed. In HS420 the expression was significantly upregulated 
compared to all other cell lines indicating that this cell line contains cells with a 
differentiation potential towards trophectodermal cells. Placental cells are a 
steroidogenic cell type expressing βHCG and this could explain the upregulation of 
NR5A1 and HSD3B in this cell line. Spontaneous differentiation into trophectodermal 
cells in embryoid bodies has been described before [129].  
We confirmed that hES cell lines differ in their expression profiles and have different 
dispositions towards individual differentiation pathways. Cultivation on laminin 
maintained the pluripotency and self-renew capacity of all seven cell lines for at least 
four passages. We found cell lines, i.e. HS361 and HS420, with a tendency to 
differentiate into Sertoli and steroidogenic cells. 
  
In conclusion, we found that there are two distinguished steroidogenic cell types in 
the postnatal rat testis and that the peritubular cells in both, rodents and humans, 
contain putative stem Leydig cells. Furthermore, we showed that embryonic stem 
cell lines have different expression profiles and that a carefully chosen cell line could 
provide a starting point for further targeted differentiation studies. 
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5 CONCLUDING REMARKS 
In this thesis, different stages of Leydig cell development and human embryonic 
stem cells have been analyzed to elucidate the origin of the adult Leydig cell lineage 
and to identify mechanisms that are involved in the differentiation towards 
steroidogenic cells. 
The postnatal fetal Leydig cells showed to retain a capacity to produce steroids 
especially upon stimulation with hCG or cAMP, but lost this ability within 72 hours in 
culture due to an attenuation of P450c17 translation. Furthermore, signs of 
dedifferentiation were found under in vitro conditions as shown by the 
downregulation of steroidogenic enzyme and mature Leydig cell markers like LHR 
and Insl3. 
Treatment with (Bu)2cAMP led to an increase of steroidogenic gene expression as 
well as steroid production, indicating that cAMP-PKA signaling is involved in the 
regulation of steroidogenesis. Both, cAMP and PDGF-A stimulation, increased the 
proliferative activity of FLCs. 
The PDGFRα-positive peritubular cells isolated from neonatal rat testis expressed 
markers for pluripotency, stem Leydig cells, peritubular and steroidogenic cells but 
no factors expressed by mature Leydig cells. This suggests that they are possible 
precursor cells for the adult Leydig cell lineage. Freshly isolated, the cells produce 
low levels of testosterone and progesterone. The production is increased upon 
(Bu)2cAMP stimulation, which indicates that the cAMP-PKA signaling is also involved 
in the regulation of steroidogenesis in this cell type. 
Electronmicroscopy studies support that the human testicular peritubular cells can 
host a Leydig cell precursor population. The HTPCs were shown to express the 
PDGFRα and markers for pluripotency, peritubular and steroidogenic cells, without 
the expression of mature Leydig cell markers. Stimulation of the cAMP-PKA 
signaling led to an increase in steroidogenic gene expression and steroid production 
after 6 and 24 hours. Furthermore, treatment with PDGF-B increased the StAR 
expression indicating a possible link between the PDGF-signaling and 
steroidogenesis. 
Taken together, these findings suggest that the HTPCs are related to the adult 
Leydig cell lineage. 
Seven human embryonic stem cell lines were analyzed for their differentiation 
potential towards gonadal cells. HS361 expressed higher levels of Sertoli cell 
markers than the other six cell lines, and HS420 expression patterns resembled 
more steroidogenic cell expression patterns, but also included the placental cell 
marker HCGB. To draw conclusions about mechanisms underlying steroidogenic 
cell differentiation, a continuation of the project with successful differentiation 
towards the Leydig cell lineage would be needed.  
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In Project 1 and 2, rat testicular cells were studied. Rodents and rats especially are 
commonly used for studies of testicular structure and function. Their morphological 
features are comparable to most other mammalian species, and rats are the most 
common animal model in reproduction and toxicology studies. However, conclusions 
from animal experiments need to be validated in humans. 
Due to obvious ethical reasons, the possibilities to study human material are limited. 
The outgrow cultures of peritubular cells from human testicular biopsies as described 
in Project 3 are a useful model to study various aspects of human testicular 
peritubular cells and offer a unique possibility to validate the findings of Project 2 in 
human cells.  
 
The results of this work provide new insights into the origin of the adult Leydig cell 
lineage. PDGFRα-positive peritubular cells are possible precursors for ALCs and the 
cAMP-PKA pathway is involved in the regulation of steroidogenesis and 
differentiation towards steroidogenic cells.  
All findings of this work originate from in vitro studies and need to be validated in in 
vivo studies before clinical implications can be considered.  
The identification of differentiation mechanisms for gonadal cells and the exploitation 
of pluripotent stem cells in the recreation of testicular tissue may become an 
important approach to (re)-establish fertility in sub- or infertile men. 
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6 FUTURE PERSPECTIVES 
Overall, there seems to be a relationship between the two generations of Leydig 
cells and the peritubular cell lineage. The cAMP-PKA pathway plays an important 
role in the regulation of steroidogenesis in all three cell types and PDGF signaling is 
involved in the regulation of their proliferation and steroidogenesis. 
Human ES cell lines have the potential to differentiate into all cell types of the human 
body, mechanisms underlying the differentiation into gonadal cell types have to be 
further explored to understand the development of the testis. 
To further analyze the fate of fetal Leydig cells and to elucidate their possible role in 
the adult testis, it would be interesting to examine the mechanisms of their 
dedifferentiation and to find signaling pathways to prevent it. To study FLC behavior 
in vivo, isolated fetal Leydig cells could be transplanted into Leydig cell depleted rat 
testes after EDS treatment and their capacity to repopulate the interstitium and to 
produce steroids could be studied.    
Our work provided evidence that the peritubular cells are a possible source of the 
adult Leydig cell lineage. We found characteristics of pluripotent and steroidogenic 
cells in our isolated PDGFRα-positive cell population. To confirm these results in 
vivo, experiments similar to those described for the FLCs should be performed, 
including transplantation of GFP positive PTCs after EDS treatment.  
Another aim for a future study of peritubular cells and their relation to the Leydig cell 
lineage is successful differentiation of peritubular cells into testosterone producing 
mature Leydig cells. Short-time stimulation of the cAMP-PKA pathway led to an 
increase in pregnenolone and progesterone production as well as to steroidogenic 
gene expression, but no testosterone was produced. PDGF-B stimulated StAR 
expression in the HTPCs after 24 hours, but did not further increase steroidogenesis.  
A promising study by Ge et al. described differentiation of rat stem Leydig cells into 
3βHSD-positive cells grown in differentiation medium containing a combination of 
factors including LH, IGF-1, T3 and PDGF [1]. However, testosterone production of 
these cells was very low [1] and these results need to be confirmed for human 
peritubular cells. 
Our understanding of differentiation pathways underlying development of gonadal 
cells is still limited. After identification of the possible hES cell lines as candidates for 
different gonadal cell types, their differentiation capacity into the different cell lines 
needs to be further defined.  
Different experimental approaches, such as spontaneous differentiation in embryoid 
body formation, directed differentiation following published differentiation protocols, 
and the targeted induction of differentiation pathways, such as the cAMP-PKA 
pathway in the differentiation towards steroidogenic cells, could be compared.  
Differentiation success has to be confirmed by functional studies and transplantation 
of differentiated cells. 
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To be able to help patients suffering from infertility, a lot of information about the 
development of the gonadal cells has yet to be collected. Being able to use stem cell 
technology to create all testicular cell types in vitro could help to identify 
differentiation mechanisms and to restore spermatogenesis and steroidogenesis. 
This knowledge could be used to re-establish fertility-potential in a subpopulation of 
infertile men.  
Male survivors of childhood cancer having undergone gonadotoxic treatment or of 
other severe systemic diseases are an increasing group of patients that will profit 
from this research in the future. 
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